Effect of Perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunction

American Journal of Cardiology

Volumn 93, Issue 11, 2004, Pages 1438-1440

  Chirkov, Yuliy Y ^a   Holmes, Andrew S ^a   Martelli, Jason D ^a   Horowitz, John D ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PERINDOPRIL; SUPEROXIDE;

ANTICOAGULATION; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CYCLIC GMP; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PERINDOPRIL; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; SUPEROXIDES; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 2542448211     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.02.052     Document Type: Article

References (12)

1. Ignarro L.J. Nitric oxide as a unique signalling molecule in the vascular system a historical overview. J Physiol Pharmacol. 53:2002;503-514
2. Walford G., Loscalzo J. Nitric oxide in vascular biology. J Thromb Haemost. 1:2003;2112-2118
3. Chirkov Y.Y., Holmes A.S., Chirkova L.P., Horowitz J.D. Nitrate resistance in platelets from patients with stable angina pectoris. Circulation. 100:1999;129-134
4. Chirkov Y.Y., Holmes A.S., Willoughby S.R., Stewart S., Wuttke R.D., Sage P., Horowitz J.D. Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets. J Am Coll Cardiol. 37:2001;1851-1857
5. MacCarthy P.A., Shah A.M. Oxidative stress and heart failure. Coron Artery Dis. 14:2003;109-113
6. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 74:1994;1141-1148
7. Sorescu D., Somers M.J., Lassegue B., Grant S., Harrison D.G., Griendling K.K. Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. Free Radic Biol Med. 30:2001;603-612
8. Rueckschloss U., Quinn M.T., Holtz J., Morawietz H. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 22:2002;1845-1851
9. Storey R.F., Heptinstall S. Laboratory investigation of platelet function. Clin Lab Haematol. 21:1999;317-329
10. Refaai M.A., Laposata M. Platelet aggregation. Michelson A.D. Platelets. 2002;291-296 Academic Press, London
11. Ellis G.R., Anderson R.A., Chirkov Y.Y., Morris-Thurgood J., Jackson S.K., Lewis M.J., Horowitz J.D., Frenneaux M.P. Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure. J Cardiovasc Pharmacol. 37:2001;564-570
12. Anderson R.A., Ellis G.R., Chirkov Y.Y., Holmes A.S., Payne N., Blackman D.J., Jackson S.K., Lewis M.J., Horowitz J.D., Frenneaux M.P. Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failure. Eur J Heart Fail. 6:2004;47-54